Baird


This Top Analyst Is Bullish on Alphabet Inc (GOOGL) Amid Apigee Acquisition

This morning, Alphabet Inc (NASDAQ:GOOGL) announced plans to acquire API management platform Apigee for a total of $625 million or $17.40 per share in …

Facebook Inc (FB) Investor Concerns Are Likely Overblown: Top Analyst

Baird top analyst Colin Sebastian provides commentary on Facebook Inc (NASDAQ:FB) on the heels of discussions with worried investors who question the social …

Baird Pounds the Table on Tesla Motors Inc (TSLA)

Baird analyst Ben Kallo was out pounding the table on Tesla Motors Inc (NASDAQ:TSLA), reiterating an Outperform rating and price target of $338, which …

Baird Weighs in on Alphabet Inc (GOOGL) Amid Expansion of Ride-Sharing Service in San Fransisco

The Wall Street Journal reported that Alphabet Inc (NASDAQ:GOOGL) will be expanding its Uber and Lyft rival ride-sharing service in San Fransisco, intending …

Baird Reiterates Bullish Stance on J.C. Penney Company Inc (JCP) Following Analyst Day

Baird commends CEO Ellison’s new management direction and hopes to gain more confidence longer-term

Top Analyst: We Would Be Buyers of PayPal Holdings Inc (PYPL) Following Visa Partnership

Baird top analyst Colin Sebastian provides commentary on shares of Paypal Holdings Inc (NASDAQ:PYPL) in light of a spiral of mixed investor concern …

Baird Lowers Price Target for Merrimack Pharmaceuticals Inc (MACK) on Back of Lower Onivyde Revenues

Baird analyst Michael Ulz gave his two cents on Merrimack Pharmaceuticals Inc (NASDAQ:MACK), following the company’s second-quarter earnings report. MACK saw Onivyde, its first …

This Top Analyst Remains Bullish On Alibaba Group Holding Ltd (BABA) Following Public Sales Meeting

With AliCloud seeking to become a real competitor in North America, Baird’s top analyst Colin Sebastian weighs in on Alibaba Group Holding Ltd (NYSE:BABA). …

Baird’s 2Q Earnings Preview: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG)

Analyst Brian Skorney from Baird discussed Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG) ahead of their second-quarter earnings reports.

Baird Analyst Reiterates Outperform on Intel Corporation (INTC) Following In-Line 2Q Report

Baird analyst, Tristan Gerra, reiterates an Outperform rating on Intel Corporation (NASDAQ:INTC) following the company’s 2Q earnings report. According to the analyst, INTC reported EPS of $0.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts